TLRY - Tilray Brands, Inc.
IEX Last Trade
1.43
0.010 0.699%
Share volume: 434,335
Last Updated: Fri 27 Dec 2024 08:30:12 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$1.42
0.01
0.70%
Fundamental analysis
24%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
40%
Performance
5 Days
3.50%
1 Month
8.03%
3 Months
-14.94%
6 Months
-14.45%
1 Year
-33.93%
2 Year
-43.73%
Key data
Stock price
$1.43
DAY RANGE
$1.40 - $1.52
52 WEEK RANGE
$1.22 - $2.97
52 WEEK CHANGE
-$35.65
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/03/2024
Company detail
CEO: Irwin D. Simon
Region: US
Website: tilray.com
Employees: 1,700
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: tilray.com
Employees: 1,700
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company operates Tilray Medical, which provides GMP-certified flowers, oils, vapes, edibles, and topicals.
Recent news